Iodixanol
Radiographic Contrast Agent — VARIOUS
Also known as: visipaque
Data last refreshed: (DrugCentral release 2024-11-01)
Key facts
Iodixanol is a drug in the Radiographic Contrast Agent class catalogued in DrugCentral. It was first approved by the FDA in 1996. Its mechanism of action is classified as X-Ray Contrast Activity.
- Drug class: Radiographic Contrast Agent.
- Mechanism of action: X-Ray Contrast Activity.
- ATC code: V08AB09 (Watersoluble, nephrotropic, low osmolar X-ray contrast media).
- Molecular formula: C35H44I6N6O15; molecular weight 1550.19 g/mol.
Mechanism & targets
| Mechanism of action (MoA) | X-Ray Contrast Activity |
|---|---|
| Established pharmacologic class | Radiographic Contrast Agent |
Regulatory approvals (1)
| Date | Agency | Marketed as | Applicant | Orphan |
|---|---|---|---|---|
| 1996-03-22 | FDA | — | GE HEALTHCARE |
ATC classification
| ATC code | Therapeutic hierarchy |
|---|---|
V08AB09 | VARIOUS › CONTRAST MEDIA › X-RAY CONTRAST MEDIA, IODINATED › Watersoluble, nephrotropic, low osmolar X-ray contrast media |
Reported adverse-event signals
Strongest FDA FAERS disproportionality signals (log-likelihood ratio). A signal is a statistical association in spontaneous reports, not proof that the drug causes the event.
| MedDRA term | LLR |
|---|---|
| Pruritus | 596.4 |
| Contrast media allergy | 523.2 |
| Erythema | 392.0 |
| Contrast media reaction | 387.8 |
| Acute generalised exanthematous pustulosis | 289.9 |
| Urticaria | 287.6 |
| Contrast encephalopathy | 227.9 |
| Rash | 224.9 |
| Anaphylactic reaction | 219.1 |
| Rash maculo-papular | 204.8 |
| Acute kidney injury | 177.0 |
| Swelling face | 153.5 |
Chemical structure
Full physicochemical, ADMET and 3D-structure analysis of Iodixanol is on its molecule page.
| Molecular formula | C35H44I6N6O15 |
|---|---|
| Molecular weight | 1550.19 g/mol |
| CAS number | — |
| InChIKey | NBQNWMBBSKPBAY-UHFFFAOYSA-N |
| PubChem CID | 3724 |
Frequently asked questions
Answers are generated from the structured data on this page, not written by hand.
How does Iodixanol work?
Iodixanol is classified as X-Ray Contrast Activity.
When was Iodixanol first approved?
Iodixanol was first approved by the FDA in 1996.
What drug class does Iodixanol belong to?
Iodixanol is in the Radiographic Contrast Agent class.
What is the chemical formula of Iodixanol?
Iodixanol has the molecular formula C35H44I6N6O15 and a molecular weight of 1550.19 g/mol.
Browse: all drugs starting with I · drug guides by category · protein targets A–Z.
Sources
- DrugCentral drug card 3302 — structure, indications, targets, approvals, pharmacologic classes (CC BY-SA 4.0)
- ChEMBL CHEMBL1200507 — compound record and bioactivity
- PubChem CID 3724 — chemical identifiers
- DrugBank DB01249 — drug record
- FDA UNII HW8W27HTXX — substance identity
- DailyMed: FDA labels for Iodixanol — current prescribing information (label search)
- FDA Adverse Event Reporting System (openFDA FAERS) — adverse-event signals, as aggregated by DrugCentral
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.